Wang Q - Search Results

1

Imatinib and bortezomib induce the expression and distribution of anaphase-promoting complex adaptor protein Cdh1 in blast crisis of chronic myeloid leukemia.

Wang Q, Zhou HS, Huang KK, Jiang XJ, Wu FQ, Cao R, Yin CX, Liao LB, Zheng ZX, He H, Lin R, Yi ZS, Xu D, Yang M, Meng FY. Wang Q, et al. Int J Oncol. 2012 Feb;40(2):418-26. doi: 10.3892/ijo.2011.1233. Epub 2011 Oct 13. Int J Oncol. 2012. PMID: 22002244

2

[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism].

Jiang XJ, Meng FY, Zhou HS, Wang Q, Wu FQ, Huang KK, Huang M, Wang ZX, Chen WW. Jiang XJ, et al. Among authors: wang zx, wang q. Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):537-42. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22338177 Chinese.

3

Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways.

Jiang XJ, Huang KK, Yang M, Qiao L, Wang Q, Ye JY, Zhou HS, Yi ZS, Wu FQ, Wang ZX, Zhao QX, Meng FY. Jiang XJ, et al. Among authors: wang zx, wang q. Cancer Lett. 2012 Dec 30;326(2):135-42. doi: 10.1016/j.canlet.2012.07.030. Epub 2012 Aug 1. Cancer Lett. 2012. PMID: 22863538

4

Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia.

Yu G, Chen F, Yin C, Liu Q, Sun J, Xuan L, Fan Z, Wang Q, Liu X, Jiang Q, Xu D. Yu G, et al. Among authors: wang q. Oncotarget. 2017 Oct 31;8(63):107022-107032. doi: 10.18632/oncotarget.22206. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291008 Free PMC article.

5

Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.

Yu G, Yin Z, He H, Zheng Z, Chai Y, Xuan L, Lin R, Wang Q, Li J, Xu D. Yu G, et al. Among authors: wang q. J Clin Lab Anal. 2020 Mar;34(3):e23096. doi: 10.1002/jcla.23096. Epub 2019 Nov 6. J Clin Lab Anal. 2020. PMID: 31691380 Free PMC article.

6

A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.

He B, Wang Q, Liu X, Lu Z, Han J, Pan C, Carter BZ, Liu Q, Xu N, Zhou H. He B, et al. Among authors: wang q. Biomed Pharmacother. 2020 Sep;129:110390. doi: 10.1016/j.biopha.2020.110390. Epub 2020 Jun 17. Biomed Pharmacother. 2020. PMID: 32563150 Free article.

7

Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients.

Wang Q, Yu G, He H, Zheng Z, Li X, Lin R, Xu D. Wang Q, et al. Cell Biol Int. 2021 Apr;45(4):869-881. doi: 10.1002/cbin.11534. Epub 2020 Dec 31. Cell Biol Int. 2021. PMID: 33325145

8

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation.

Xu D, Chen Y, Yang Y, Yin Z, Huang C, Wang Q, Jiang L, Jiang X, Yin C, Liu Q, Yu G. Xu D, et al. Among authors: wang q. J Transl Med. 2022 Jul 6;20(1):300. doi: 10.1186/s12967-022-03498-1. J Transl Med. 2022. PMID: 35794565 Free PMC article.

9

Simultaneous analysis of telomere length and cell surface antigen in leukemia by multicolor Flow-FISH.

Zhan Y, Feng R, Yi ZS, Song LL, Wang Q, Xu M, Wei YQ. Zhan Y, et al. Among authors: wang q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1395-401. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21176337

10

[Effect of RAD001 or plus LBH589 on the proliferation, apoptosis and drug resistance in chemoresistant acute myeloid leukemic cells].

Jiang XJ, Meng FY, Huang KK, Zhou HS, Wang Q. Jiang XJ, et al. Among authors: wang q. Zhonghua Yi Xue Za Zhi. 2011 Aug 30;91(32):2287-92. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22094098 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,747 results

Search Page

Filters